Lancaster EPrints

A Bayesian approach for dose-escalation in a phase I clinical trial incorporating pharmacodynamic endpoints .

Whitehead, John and Hampson, Lisa and Zhou, Yinghui and Ledent, Edouard and Pereira, Alvaro (2007) A Bayesian approach for dose-escalation in a phase I clinical trial incorporating pharmacodynamic endpoints . Journal of Biopharmaceutical Statistics, 17 (6). pp. 1117-1129. ISSN 1520-5711

[img]
Preview
PDF (Microsoft_Word_-_JBS_paper__revised__-_15-06-07.pdf)
Download (230Kb) | Preview

    Abstract

    Bayesian decision procedures have already been proposed for and implemented in phase I dose-escalation studies in healthy volunteers. The procedures have been based on pharmacokinetic responses reflecting the concentration of the drug in blood plasma and are conducted to learn about the dose-response relationship while avoiding excessive concentrations. However, in many dose-escalation studies, pharmacodynamic endpoints such as heart rate or blood pressure are observed, and it is these that should be used to control dose-escalation. These endpoints introduce additional complexity into the modelling of the problem relative to pharmacokinetic responses. Firstly, there are responses available following placebo administrations. Secondly, the pharmacodynamic responses are related directly to measurable plasma concentrations, which in turn are related to dose. Motivated by experience of data from a real study conducted in a conventional manner, this paper presents and evaluates a Bayesian procedure devised for the simultaneous monitoring of pharmacodynamic and pharmacokinetic responses. Account is also taken of the incidence of adverse events. Following logarithmic transformations, a linear model is used to relate dose to the pharmacokinetic endpoint and a quadratic model to relate the latter to the pharmacodynamic endpoint. A logistic model is used to relate the pharmacokinetic endpoint to the risk of an adverse event.

    Item Type: Article
    Journal or Publication Title: Journal of Biopharmaceutical Statistics
    Additional Information: Author Posting. (c) Taylor & Francis, 2007. This is the author's version of the work. It is posted here by permission of Taylor & Francis for personal use, not for redistribution.The final, definitive version of this article has been published in the Journal, Journal of Biopharmaceutical Statistics , 17 (6), 2007, © Informa Plc
    Uncontrolled Keywords: Bayesian procedure ; Dose-escalation ; Pharmacodynamic responses ; Phase I clinical trial
    Subjects: Q Science > QA Mathematics
    Departments: Faculty of Science and Technology > Mathematics and Statistics
    ID Code: 903
    Deposited By: Professor John Whitehead
    Deposited On: 09 Jan 2008 10:22
    Refereed?: Yes
    Published?: Published
    Last Modified: 09 Oct 2013 14:50
    Identification Number:
    URI: http://eprints.lancs.ac.uk/id/eprint/903

    Actions (login required)

    View Item